Imaxio, German Cancer Research Center deal

Imaxio granted the center an option to license rights to Imaxio’s IMX313 technology.

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE